Matrix-Degrading Type II Transmembrane Serine Protease Matriptase: Its Role in Cancer Development and Malignancy

    October 2006
    Ming‐Shyue Lee
    TLDR Matriptase imbalance contributes to cancer development and spread.
    Matriptase, a type II transmembrane serine protease derived from epithelial cells, played a crucial role in epithelial homeostasis and was implicated in cancer development and progression. It was regulated by its inhibitor, HAI-1, which controlled its expression, trafficking, and activity. In animal models, matriptase was essential for postnatal survival, epidermal barrier function, and hair follicle development. Deregulation of matriptase led to carcinogenesis and malignant transformation, with imbalances in matriptase and HAI-1 expression being linked to cancer stages. This malfunction significantly contributed to cancer development and metastasis.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results